Skip to product information
1 of 1

Elabscience

SKU:E-AB-F1101UE

APC Anti-Mouse IFN-γ Antibody[XMG1.2]

APC Anti-Mouse IFN-γ Antibody[XMG1.2]

Regular price $200.00 USD
Regular price Sale price $200.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Concentration
Host

APC Anti-Mouse IFN-γ Antibody[XMG1.2]

The APC Anti-Mouse IFN-γ Antibody [XMG1.2] is a highly specific and reliable tool designed for the detection and quantification of mouse interferon-gamma (IFN-γ) in various research applications. This antibody is conjugated with allophycocyanin (APC), a bright and photostable fluorochrome, enabling easy and efficient detection of IFN-γ in flow cytometry experiments.

The XMG1.2 antibody exhibits exceptional specificity towards mouse IFN-γ, ensuring minimal cross-reactivity with other cytokines or proteins. This specificity is crucial for accurate and reliable results in immunological studies. The antibody has been extensively validated and optimized to provide consistent and reproducible performance, making it an ideal choice for researchers working in immunology, infectious diseases, cancer research, and other related fields.

In addition to its exceptional specificity, the APC Anti-Mouse IFN-γ Antibody [XMG1.2] offers excellent sensitivity, allowing for the detection of low levels of IFN-γ in samples. This sensitivity is particularly advantageous when working with limited sample volumes or when studying low-abundance cytokines. The APC conjugate provides a strong and stable signal, ensuring reliable and precise quantification of IFN-γ expression levels in both in vitro and in vivo experimental settings.

Overall, the APC Anti-Mouse IFN-γ Antibody [XMG1.2] is a valuable tool for researchers seeking to investigate the role of IFN-γ in various biological processes. Its exceptional specificity, sensitivity, and reliability make it an essential component of any immunological research project. With this antibody, researchers can confidently explore the intricate mechanisms underlying immune responses, paving the way for advancements in therapeutic interventions and disease management.

View full details